Russia’s Ministry of Health refutes misleading online claim that it stated COVID-19 is man-made – AFP Factcheck

Multiple articles and social media posts viewed tens of thousands of timesclaimthe Russian Ministry of Health confirmed in a document that the novel coronavirus, COVID-19,is man-made.The claim is misleading; the RussianMinistry of Health said it did not make such astatement; the documentcited in the misleading postsstates COVID-19is a recombinant virus which can form naturally.

The claim was made in this report by Taiwanese news site CredereMedia. The article has been viewed almost 150,000 times on Facebook after it was published on February 21, 2020, according to statistics from social media monitoring tool CrowdTangle.

The article's traditional Chinese-language headline translates to English as: The first official confirmation in the world: Russian Ministry of Health says Wuhan pneumonia is caused by a man-made virus.

The photo in the article is captioned: Russian health minister Mikhail Murashko (pictured left) signs a document confirming the source of the Wuhan pneumonia is a man-made recombinant virus."

The article reports onRussia's measures to combat the novel coronavirus, as well ason China'sdenials that the virus was created as a biological weapon.

Below is a screenshot of the misleading post alongside CrowdTangle statistics:

The claim was also shared in Facebook groups with hundreds of thousands of followers, such as here, here, here and here. It has also circulated on Twitter here, here, here and here as well as on Instagram here and here.

The claim is misleading.

The Russian Ministry of Health has never indicated that the virus was of artificial origin in its recommendations on the prevention, diagnosis and treatment of the new coronavirus, a Ministry of Health spokesperson told AFP by email on February 27, 2020.

Regarding the alleged document, the misleading posts refer to a report published late January by the Russian Ministry of Health.

A search forcoronavirus on the ministrys website found the Temporary guidelines for the prevention, diagnosis, and treatment of the new 2019-nCoV coronavirus infection, which was published on January 30, 2020.

Coronavirus 20190nCov is presumably a recombinant virus, between a bat coronavirus and a coronavirus whose origin is unknown, part of the Russian report reads in English.

Professor William Robert Fleischmann Jr., an expert on viruses and immunology, noted in his co-authored academic book Medical Microbiology that recombinant viruses can form naturally.

Viruses are continuously changing as a result of genetic selection. They undergo subtle genetic changes through mutation and major genetic changes through recombination, the book stated. Mutation occurs when an error is incorporated in the viral genome. Recombination occurs when coinfecting viruses exchange genetic information, creating a novel virus.

A research paper published here in January 2020 in the Journal of Medical Virology also explains how recombination can be a natural process.

The report, which is titled Crossspecies transmission of the newly identified coronavirus 2019nCoV, states that the coronavirus may appear to be a recombinant virus between the bat coronavirus and an originunknown coronavirus.

A claimthat the deadly virus was created in a laboratory, and specifically by the US Centers for Disease Control and Prevention, was previously debunked by AFP here.

Read the rest here:
Russia's Ministry of Health refutes misleading online claim that it stated COVID-19 is man-made - AFP Factcheck

Northwell creates institute for gun violence prevention – The Island Now

Northwell Health System announced the creation of an institute to study gun violence prevention on Wednesday.

The Center for Gun Violence Prevention was established by its President and CEO Michael Dowling to help curtail the nearly 40,000 firearms-related deaths that occur every year in the U.S.

I firmly believe that health care leaders have a social responsibility to try to stop the mindless bloodshed caused by firearms-related violence in this country, just as we respond aggressively to health crises like vaping, the flu or the new coronavirus that is causing worldwide panic, said Dowling, who has called gun violence a major health problem and called on other hospital groups to support legislation to address the problem.

The center will be headed by Dr. Chethan Sathya, a pediatric surgeon and associate trauma medical director at Cohen Childrens Medical Center, whose trauma surgery training at Northwestern Medicines Childrens Hospital in Chicago, Ill. involved treating infants with gunshot wounds.

Our goal is to build a blueprint for how health systems across the nation can reduce gun violence and promote gun safety, Sathya said. If we can develop a successful gun violence prevention strategy internally, it will serve as an example for other health systems and industries to follow suit. We want to lead the charge on this and show others that meaningful change is possible and that lives can be saved.

Northwells Deputy Physician-in-Chief Thomas McGinn will assist, as will Dr. Jose Prince, vice chair of surgery at Northwell and director of the Laboratory of Pediatric Injury and Inflammation at the Feinstein Institutes Center for Immunology and Inflammation.

Multiple prominent voices on gun violence prevention have agreed to serve on an advisory committee that will guide the new interdisciplinary center, including Dr. Peter Masiakos, founder of Massachusetts General Hospitals Center for Gun Violence Prevention and assistant professor at Harvard Medical School; Dr. Robert McLean, president of the American College of Physicians and associate clinical professor at Yale Medical School; Dr. Megan Ranney, chief research officer of the American Foundation for Firearm Injury Reduction in Medicine Research; Dr. Mark Rosenberg, former head for the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention and former CEO of the Task Force for Global Health; and Daniel Webster, director of Johns Hopkins Center for Gun Policy and Research and a leader at the Johns Hopkins-Baltimore Collaborative for Violence Reduction.

Dowling, who served as state director of Health, Education and Human Services, has been outspoken on gun violence as a public health crisis. He ran advertisements in The New York Times last summer calling for efforts to combat the problem, held Northwells Gun Violence Prevention Forum last fall and wrote an editorial in the August issue of Beckers Hospital Review on the subject.

True leadership means having the personal courage to speak out and take the heat, particularly on issues that are affecting the health and wellness of our communities, Dowling wrote. If there was a disease that was killing as many people as guns in this country, we would be mobilizing a national response effort. Its inexcusable for us to remain silent.

Originally posted here:
Northwell creates institute for gun violence prevention - The Island Now

Coronavirus circulated ‘unnoticed for weeks’ in Italy, expert says – Daily Sabah

The new coronavirus had been "circulating unnoticed for weeks" in Italy, experts said Friday after studying its progression in the country.

"The virus circulated unnoticed for several weeks before the first ascertained cases ... perhaps since mid-January," Massimo Galli, the director of the Biomedical Research Institute, told Agence France-Presse (AFP). Studying the virus in Italy "will help understand the epidemic better, and contain it," he said.

The virus mutates from person to person, he said, so researchers will be looking at why Italy has the largest number of cases in Europe and "the differences between this and the coronavirus in China." That will help in terms of treatment and the potential development of a vaccine, he added.

Some 650 people have tested positive for the virus in Italy, though only 303 are considered serious clinical cases.

Galli's team at the Sacco hospital in Milan, led by immunology professor Claudia Balotta, worked on samples taken from three patients in the "red zone" around Codogno in Lombardy, home to Italy's first known case of COVID-19. They isolated the Italian strain in just four days.

The small town of Codogno in northern Italy is home to a 38-year-old man dubbed "patient one." "Patient zero," who passed the virus to the 38-year-old, has yet to be found, but "patient one" is considered the source of both the Codogno outbreak and another in the Veneto region.

The 38-year-old hospitalized a week ago passed the virus to his heavily pregnant wife, a friend and men who were regulars at a bar in Codogno, before going on to infect doctors, nurses and other hospital patients as well.

The virus has killed 17 people in Italy over the past week, all of whom were either elderly or had pre-existing health issues.

The number of cases of infection reported has risen steadily each day, though Galli said that did not mean the virus was spreading. Most were people who had caught it previously but had not been tested until now.

Bilotta said it would "take weeks" to determine the exact date of arrival of this strain in Italy, saying results would likely only come "once the epidemic is over."

View original post here:
Coronavirus circulated 'unnoticed for weeks' in Italy, expert says - Daily Sabah

New ammunition uncovered by U of T researchers to develop colorectal cancer treatment – Varsity

One in 14 Ontarians can expect to be diagnosed with colorectal cancer in their lifetime. COURTESY OF ED UTHMAN/FLICKR

University of Toronto scientists have identified a key protein as a common factor in the growth of many different types of colorectal cancer tumours, according to research published in the Journal of Cell Biology. Colorectal cancer develops in the colon or rectum. In Ontario, it is also the second most fatal cancer, and one in 14 Ontarians can expect to be diagnosed with this form of cancer in their lifetime.

In past research, scientists have linked the excessive accumulation of beta-catenin, a protein with crucial functions in cell development, to the expression of genes that drive tumour proliferation. Research has associated 80 per cent of colorectal cancers with gene mutations that greatly increase the production of beta-catenin.

The co-authors of the study have identified another protein, Importin-11, as the compound that enables beta-catenin transportation to the nucleus of the human cell. Cancer therapies that inhibit this transport could be a promising way to treat colorectal cancer.

Fundamental research provides new knowledge for cancer therapies

The Varsity spoke to Dr. Stephane Angers, a co-author of the study and an associate professor at U of Ts Department of Biochemistry. Angers lab has spent a considerable amount of time studying biological pathways the series of chemical changes during cellular development that give cells their final functions.

Angers noted that Monika Mis, the lead author of the study and a PhD student, uncovered the role of Importin-11 in colorectal cancer in Angers lab. Mis used the gene-editing CRISPR-Cas9 technology to screen genes in colorectal cancer calls to identify a novel gene, IPO11, which encodes for the protein Importin-11.

Current treatment options for colorectal cancer include surgery, chemotherapy, and other radiation therapy. Although this discovery is still in its fundamental stages, blocking the transport of beta-catenin holds great promise for developing new therapies.

As Angers put it, It provides new ammunition, new possibilities, and new knowledge that could lead in the future to new therapies, but it is very much at the discovery level at this point.

More research required to develop therapies

Further research could involve drug discovery and widen the scope of Importin-11 function in various cells. Researchers may also find it valuable to analyze existing data about colorectal cancer. The goal is to understand how the mutations affect tumour formation and develop therapies that harness this knowledge.

Angers lab is also investigating other potential applications of the Wnt pathway, a specific biological pathway associated with beta-catenin. A particularly interesting aspect is its role in regenerative medicine, which is the study of restoring human cells, tissues, and organs.

We think that with new molecules that we have developed we can now activate the pathway in order to promote the regenerative abilities of tissues, noted Angers.

Tags: biology, cancer, medicine, oncology

Read the original post:
New ammunition uncovered by U of T researchers to develop colorectal cancer treatment - Varsity

Sally Cheshire CBE appointed as Interim Chair of Cafcass – Mirage News

The Secretary of State has announced the appointment of Sally Cheshire CBE as Interim Chair of the Children and Family Court Advisory and Support Service (Cafcass). Sallys term of office will run from 16 December until 30 June 2020 whilst a recruitment campaign is carried out to fill the position on a permanent basis.

The role of Cafcass Chair is regulated by the Commissioner for Public Appointments and has been made in line with the Governance Code on Public Appointments.

Cafcass is an independent (non-departmental) public body which has a statutory responsibility to safeguard and promote the welfare of children going through family proceedings. It is independent of the courts, social services, education and health authorities and all similar agencies.

Cafcass ensures that children and young people who are the subject of such proceedings are kept safe, their voices are properly heard, the decisions made about them by courts are in their best interests and that they and their families are supported throughout the process.

Sally Cheshire has been a member of Cafcass since May 2018, and was appointed as Deputy Chair in February 2019. Sally is Chair of the Human Fertilisation and Embryology Authority (HFEA), the UKs regulator of the fertility sector and embryo research, has held senior leadership roles across the health sector and is currently Chair of Health Education England (North). Sally was also a Board Member of the regional adoption agency Adoption Counts, and an independent member of adoption panels in the North West, which approve adopters and family matches in the best interests of children. She previously enjoyed a successful corporate career with Deloitte.

View post:
Sally Cheshire CBE appointed as Interim Chair of Cafcass - Mirage News

New IVF clinic for people living in Plymouth, Cornwall and the Isles of Scilly – Plymouth Live

A new IVF clinic is due to open in Plymouth in the coming months.

In April 2020, IVFservices will be transferred from Derriford Hospital to a 2.5M purpose-built centre.

The centre, which will provide treatment for people living in Plymouth, Cornwall and the Isles of Scilly, will be run from a bespoke new building close to the hospital, on the Plymouth International Business Park.

The current provider, University Hospitals Plymouth, gave notice in August 2019 that it no longer intended to provide fertility services that require a licence from the regulator, the Human Fertilisation and Embryology Authority (HFEA).

These services includeIVFtreatment, storage of embryos, sperm and eggs, male fertility testing and sperm preparation.

NHS clinical commissioning groups buy these services on behalf of the local population.

Following a procurement process, NHS Devon and NHS Kernow CCGs have appointed CRGW Plymouth as the new provider.

Jo Turl, director of commissioning at NHS Devon CCG said: Fertility services for NHS patients in the new clinic will continue to be provided to the high standards required both by this contract and the licence regulations imposed by the regulator, the HFEA.

We will continue to work with the new provider, NHS partners and the regulator, to ensure that people are kept informed and reassured that they will continue to be cared for by their existing NHS team.

GP referrals will not change and the new provider will continue to provide full access to these NHS services in Plymouth.

All those receiving treatment will be cared for by the same specialist team currently working in the Ocean Suite at Derriford Hospital.

Staff at Derriford Hospital will continue to provide outpatient services for people with recurrent miscarriage and specialist endocrinology clinics.

The transfer and storage of eggs, sperm and embryos is undertaken under strict HFEA rules. During the transfer of services, NHS teams will work with CRGW Plymouth to minimise any disruption and maintain the usual high quality service.

Anyone currently undergoingIVFtreatment at the hospital will not be affected.

Originally posted here:
New IVF clinic for people living in Plymouth, Cornwall and the Isles of Scilly - Plymouth Live

IVF experts warn against clinics selling ‘pointless’ add-on treatments – inews

NewsHealthExclusive: Some of these add-ons, which can cost as much as 2,500 each, could pose a 'significant risk' to patient safety

Friday, 28th February 2020, 9:50 pm

A British embryologist who trained under the father of IVF has expressed serious concerns over private fertility clinics in the UK selling pointless and potentially unsafe treatments to desperate patients.

Many British fertility patients are being seriously misled byIVF clinics which promote expensive and ineffective treatments known as add-ons which are said to improve chances of conceiving, Professor Peter Hollands has warned.

Some of these add-ons, which can cost as much as 2,500 each, could pose a significant risk to patient safety while the effectiveness of others has not been proven, he said.

Professor Hollands has decades of experience in the field and trained under the father of IVF, Professor Sir Bob Edwards, who was awarded a Nobel Prize in 2010 for pioneering the treatment.

'Pointless' extra treatments warning

i reported earlier this month that the Competition and Markets Authority was developing the first official guidelines for private fertility clinics, and said it would not rule out taking enforcement action in the future, because of the concern about add-ons.

In a paper written with fellow fertility expert Dr Nicolas Zech, Professor Hollands has cautioned against a host of add-ons, from endometrial scratching to time-lapse video monitoring of embryonic development.

Basic IVF...is clearly a safe procedure providing the option of a family to millions of people which would not otherwise be possible, the paper states.

Fertility patients might be under the impression that add-ons offered by private clinics are also safe and effective but the scientific evidence is strongly to the contrary or at best vague, it says.

Some clinics could be said to be capitalising on vulnerable patients desperation, including those experiencing depression.

The only add-on the specialists believe should be used are pre-implantation genetic diagnosis (PGD), which tests for serious genetic diseases.

'Corporate greed'

The growing number of add-ons offered is driven by patient pressure, corporate greed and the need of clinics to optimise their income, while an apparent lack of clarity surrounding these pointless treatments is also a serious concern, the paper, published in the Journal of Fertilisation, says.

IVF patients are very vulnerable even when they are totally well, Professor Hollands told i.

They are very stressed, sometimes angry...and this may turn into depression which...makes them even more likely, in their desperation, to accept almost any type of add-on offered to them by clinics.

Gwenda Burns, chief executive of the charity Fertility Network UK said: "Clinics...have a duty of care to patients, many of whom will have experienced years of distress and may be extremely vulnerable. That...should include ensuring fertility patients are given all the information they need to make the best decision for them."

The UKs fertility clinic regulator, Human Fertilisation and Embryology Authority (HFEA), said it was aware that many clinics offer optional treatments that have not been proven to increase the chances of having a baby, often at a high financial cost to the patient.

We are clear that patients should not be misled or asked to pay for treatments where there is no evidence that they will make a difference to their chances of success, it added.

The Department of Health and Social Care said: Doctors providing fertility treatment must act in the best interests of their patient and ensure the patient has consented.

The UK fertility market is worth an estimated 320m per year and is growing by around 3 per cent annually, according to a 2016 report by LaingBuisson.

Case study: 'You dont know if the treatments are valid or not'

Will*, 34, from Somerset, and his partner underwent three rounds of IVF, after which they ran out of money

The treatment plan we chose cost about 15,000. Once youre in with the clinic you end up in their system. You stop looking for any other clinics, then they say to have a monthly blood test for 180, and the drugs are on top of that.

We knew there would be extra costs, but you just dont have another option. To go somewhere else would be such a step back. You dont want to go back to square one, you just have to see it through.

You dont know if the treatments theyre suggesting are valid or not - it might be really important.

The process we went through was unbelievably gruelling. Youre just waiting and hoping the embryos will survive. Its totally crushing.

We had really lovely doctors who we felt were caring for us. Theyre telling you This 700 test could see if something else might be wrong with your sperm. Youre staring down the barrel of a life without children or paying 700.

It was an extremely isolating experience. We werent lucky on our third attempt and by that time we didnt have any money left.

Theres a huge amount of shame around IVF. The success rate is quite low but we hear so few stories about failure. The narrative is totally unbalanced - it feels like youre alone and somethings wrong with you. The language around infertility is horrible.

I dont know what wed do differently but there needs to be some kind of additional support for couples going through IVF to help them. The HFEA became somewhere we could turn to.

During IVF you have no one to talk to except the people at the clinic or your GP or some family friend who once had it five years ago. We would have paid for independent support.

Original post:
IVF experts warn against clinics selling 'pointless' add-on treatments - inews

The importance of choosing dairy calves with the right genetics for beef production – Agriland

Richie Long who farms in Ballymacarbry in Co. Waterford is a participant in the Teagasc Green Acres Calf to Beef Programme.

Richie finishes both early maturing and continental calves originating from his brothers dairy farm.These calves are finished as steers and heifers at 20-24 months-of-age.

With this arrangement, theres potential for Richie and his brothers, Michael and Liam, to work together in terms of the beef sires being used.

In addition, Richie can also be confident that the calf has been managed correctly in terms of colostrum and nutrition in the early days of life, which allow the animal to reach its weight targets in future months.

In the short video (below), the Co. Waterford-based farmer gives us a quick run through of the system operated on the farm, along with some of the changes he has made during the first year of the programme, while also outlining his plans for the future.

As AgriLand previously reported last April,for the 2019 breeding season, a team of eight beef bulls of various breeds have been selected that are positive for carcass weight and conformation, without being excessively hard-calving for the dairy herd.

After examining the cows and having been briefed on the background to the herd including parity, genetic background and calving pattern Hereford, Limousin, Belgian Blue, Charolais and Aubrac bulls were selected.

The calving difficulty of the bulls selected range from 3.2% up to 7.8%, with the easier calving bulls targeted at younger and smaller cows, while those of higher calving difficulty will be mated to older cows with a proven track record of easy calving.

Some of the calves from the above sires have now arrived on Richies farm (see video below).

In the following video, as part of the Calf Health and Management Series, National Cattle Breeding Centre (NCBC) and Munster Bovines Rose Goulding who was involved in choosing suitable sires for the calf-to-beef enterprise details how both dairy and beef farmers can build relationships and work together to produce calves that are suitable for beef production, without affecting dairy herd performance.

Rose talks us through the genetic makeup of the calves and outlines the sire selection process and why certain sires were used on different groups of cows.

Commenting on the benefits of this type of relationship, Rose said: Thepartnership here can be replicated across the cattle industry in Ireland, whereby the dairy farmer understands the beef farmers needs and visa versa.

Its a win:win situation for both parties. When they work together, the dairy farmer understands more about the beef farmers needs.

But, the beef farmer also needs to understand the dairy farmers needs, so its a real working relationship and it can really be a win:win scenario, she concluded.

Part 1:Video series: The complete guide to buying and rearing dairy-beef calvesPart 2:Video: What can I pay for dairy-beef calves?Part 3:Video: What questions should I ask dairy farmers when sourcing dairy-beef calves?

RELATED STORIES

Continue reading here:
The importance of choosing dairy calves with the right genetics for beef production - Agriland

Ancient Wheat Genome Reveals Clues to the Agricultural Past – The Scientist

As soon as he learned about the existence of ancient wheat specimens at University College Londons Petrie Museum of Egyptian Archaeology from a 2018 BBC documentary, Richard Mott of the UCL Genetics Institute wanted to study them. The samples likely contained bits of ancient wheat DNA, he reasoned, which could yield valuable insights into the history of cultivation of this all-important crop species.

Archaeobotanists at UCL helped Mott and a team of collaborators choose a handful of well-preserved husks from the museums collection of ancient emmer wheat, a variety native to the Near East and one of the first crops to be domesticated in the region, from which the researchers selected two husks for DNA extraction. After carefully removing the husks from the box, photographing them, and wrapping them in foil, the scientists transported the centuries-old plant material to a freshly bleached cleanroom used exclusively to process ancient and forensic samples.

Its fascinating to see this gene flow happening in an area important for human history.

M. Timothy Rabanus-Wallace, Leibniz Institute of Plant Genetics and Crop Plant Research

There, team member Laura Botigu, a population geneticist and visiting researcher from the Centre for Research in Agricultural Genomics (CRAG) in Barcelona, Spain, donned a hairnet, two Tyvek suits, two pairs of latex gloves, and a maskpart of a protocol designed to avoid contaminating the samples with her own cells. Uncertain how the delicate husks would hold up to the standard decontamination protocol of bleaching the samples, Botigu bleached one and left the second untouched. Then, to lyse the plants cells, she put the samples in a rotator that gently shook the husks inside an oven over the next several days. Finally, she used a centrifugation protocol to separate any DNA from the degraded cell walls and proteins.

Once the samples had been prepped and delivered to the UCL Genomics facility for sequencing, it was a waiting game to see if the procedure had yielded any readable wheat DNA. This is the more stressful part, Botigu says. Because they lack the type of protective collagen matrix found in bones, plants dont preserve ancient DNA as well as animals. You finish, the DNA is theoretically extracted, but you dont see it in the tube, says Botigu. Youre in the blind until you hear back from the sequencing services.

Within just a few weeks, the team got good news. For the husk that Botigu had bleached, about two-thirds of the reads aligned with genomes of modern wild and domesticated emmer wheat varietiesa relatively good success rate for ancient DNA, according to evolutionary geneticist Michael Scott, a postdoc in Motts lab who conducted the bio-informatics analysis of the sequences. The first surprise was how well it worked, he says. It appears that the dry conditions in Egypt were good for DNA preservation. The unbleached husk had yielded a smaller quantity of sequences, but those fragments mostly matched the ones in the bleached sample, validating the identity of those sequences as coming from the ancient wheat samples rather than from contaminants.

The museum wheat, which carbon dating showed was from between 1130 and 1000 BC, was genetically much more similar to modern domesticated varieties than to modern wild ones, suggesting that the plant lineage the samples came from had already been domesticated. Specifically, the sequences most resembled those of modern domesticated strains grown in Turkey, Oman, and India. There was also evidence for genetic exchange between the museum wheat strain and the wild emmer wheat that grew in the Levant, a large region in the Eastern Mediterranean that was a center of agricultural development in the Neolithic period, and where emmer was first cultivated. The genetic exchange could have occurred before the wheats introduction to Egypt from the Levant, says Scott. Alternatively, its possible that the ancient Egyptians wheat was able to interbreed with wild wheat in the Southern Levant thanks to interactions between the people in the two regions.

ANCIENT HUSKS: These wheat specimens were analyzed for ancient DNA by researchers at University College London.

CHRIS STEVENS

With big data and with a really good analysis method they were able to detect this gene flow, says M. Timothy Rabanus-Wallace, an agricultural geneticist at the Leibniz Institute of Plant Genetics and Crop Plant Research in Germany who coauthored a perspective published alongside the study in Nature Plants last October. Its fascinating to see this gene flow happening . . . in an area important for human history.

The bioinformatics analysis also uncovered some genetic variants in the ancient samples that werent found in any of the modern emmer wheat genomes the researchers studied. If these variants helped the wheat survive in arid locations around the Near East, perhaps introducing those sequences into modern varieties could help make them more sustainable or more drought resistant, Scott says, though he admits that this is very much just an idea.

The detection of ancient genetic variation is a notable achievement because wheat genomes are largethree to five times the length of a human genomeand repetitive, making the analysis . . . incredibly complex, says James Breen, head of the bioinformatics core at the South Australian Health and Medical Research Institute who reviewed the study and coauthored the perspective with Rabanus-Wallace, a PhD student in his lab at the Australian Centre for Ancient DNA at the time. So being able to find unique pieces of DNA in that genome is very difficult. He adds that after a couple of additional validation tests performed by the UCL team, he was convinced that the data that came out was legitimately ancient.

Botigu and Scott emphasize that the study is primarily a proof of concept that museum-kept plant samples can yield readable genetic material. We were able to look at DNA from specimens that had been stored in the museum for over 90 years without special preservation conditionsthe museum was actually even bombed and flooded during wartime, says Scott. We think our study helps demonstrate the importance of museum collections as sources of genetic data, whichin combination with new samplescan be used to uncover the history of selection on crops and their movement around the globe.

I think thats one of the biggest values of ancient DNA in plants, adds Nathan Wales, an archaeologist at the University of York who was not involved in Scott and Botigus studyto draw connections between different cultures and the different agricultural products they were growing and trading, and seeing how that changed over time.

Jef Akst is managing editor of The Scientist. Email her atjakst@the-scientist.com.

Read more:
Ancient Wheat Genome Reveals Clues to the Agricultural Past - The Scientist